John W. Huemoeller II - 06 May 2021 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Issuer symbol
AXIM
Transactions as of
06 May 2021
Net transactions value
$0
Form type
4
Filing time
23 Sep 2022, 16:17:52 UTC
Previous filing
23 Sep 2022
Next filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Option Disposed to Issuer $0 -2,000,000 -40% $0.000000 3,000,000 06 May 2021 Common Stock 2,000,000 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 6, 2021, Reporting Person voluntarily agreed to cancel the option to purchase 2,000,000 shares of the Issuer's common stock granted to Reporting Person on January 2, 2019.